Sale!

MYOZ2 Gene Cardiomyopathy familial hypertrophic type 16 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MYOZ2 Gene Cardiomyopathy Familial Hypertrophic Type 16 Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the MYOZ2 gene, which have been associated with Familial Hypertrophic Cardiomyopathy (FHC) Type 16. This condition is a form of heart disease that is inherited in an autosomal dominant pattern, characterized by the thickening of the heart’s muscle tissue (hypertrophy), which can lead to various cardiac issues, including heart failure, arrhythmias, and sudden cardiac death. The test plays a crucial role in early detection and management of the condition, enabling healthcare providers to tailor treatment plans and advise on lifestyle adjustments or interventions that may mitigate the progression of the disease or prevent its onset in at-risk individuals. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the significant value it provides in terms of personal and family health management. DNA Labs UAE, by offering this test, plays a pivotal role in advancing personalized medicine and providing critical insights into inherited cardiac conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYOZ2 Gene Cardiomyopathy familial hypertrophic type 16 Genetic Test

Welcome to DNA Labs UAE, where we offer the MYOZ2 Gene Cardiomyopathy familial hypertrophic type 16 Genetic Test. This genetic test analyzes the MYOZ2 gene for mutations associated with familial hypertrophic cardiomyopathy (FHC) type 16.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the MYOZ2 Gene Cardiomyopathy familial hypertrophic type 16 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MYOZ2 Gene Cardiomyopathy familial hypertrophic type 16 NGS Genetic DNA Test gene MYOZ2.

Test Details

Familial hypertrophic cardiomyopathy is a genetic disorder characterized by abnormal thickening of the heart muscle, leading to impaired heart function. FHC type 16 specifically occurs due to mutations in the MYOZ2 gene. Our NGS genetic test utilizes high-throughput sequencing to analyze multiple genes, including MYOZ2, to identify genetic variations or mutations.

This test is crucial in diagnosing individuals with familial hypertrophic cardiomyopathy type 16 and providing valuable information for their management and treatment. By detecting mutations in the MYOZ2 gene, this genetic test can identify individuals at risk of developing familial hypertrophic cardiomyopathy type 16, even before symptoms appear. It also assists in genetic counseling and family planning by providing information about the inheritance pattern of the condition.

It is important to note that this genetic test should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.

Test Name MYOZ2 Gene Cardiomyopathy familial hypertrophic type 16 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYOZ2 Gene Cardiomyopathy, familial hypertrophic type 16 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYOZ2 Gene Cardiomyopathy, familial hypertrophic type 16 NGS Genetic DNA Test gene MYOZ2
Test Details

MYOZ2 gene cardiomyopathy, familial hypertrophic type 16 NGS genetic test is a genetic test that analyzes the MYOZ2 gene for mutations associated with familial hypertrophic cardiomyopathy (FHC) type 16.

Familial hypertrophic cardiomyopathy is a genetic disorder characterized by abnormal thickening of the heart muscle, leading to impaired heart function. FHC type 16 is specifically caused by mutations in the MYOZ2 gene.

The NGS (Next-Generation Sequencing) genetic test is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes, including MYOZ2, to identify genetic variations or mutations. This test can help diagnose individuals with familial hypertrophic cardiomyopathy type 16 and provide valuable information for their management and treatment.

By detecting mutations in the MYOZ2 gene, this genetic test can help identify individuals at risk of developing familial hypertrophic cardiomyopathy type 16, even before symptoms appear. It can also assist in genetic counseling and family planning by providing information about the inheritance pattern of the condition.

It is important to note that this genetic test should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations based on the individual’s specific situation.